BioSpace News Archive

NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield®, and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced that the Company has received formal notification that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request for continued listing on The Nasdaq Capital Market

Elucid Bioimaging Inc. (“Elucid Bio”) today announced that vascuCAP, Elucid Bio’s AI-enabled software for evaluating atherosclerotic plaque stability from CTA, has been added to the IBM Imaging AI Marketplace, an IBM Watson Health® solution.

Company optimally positioned to increase market share in highly valued Australian hemostat market, following positive feedback from physician usage of HEMOBLAST™ Bellows

Summus Medical Laser, the leading provider of high-powered laser therapy products, announces the launch of the Horizon Medical Laser System, the first Class IV therapy laser system designed specifically for the medical industry.

RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that it has gained the rights to Movantik (naloxegol)1 in Israel from AstraZeneca (LSE/STO/Nasdaq: AZN).

Valedor Partners, LLC, a Houston-based private equity and merchant banking firm, today announced its completion of Newlight Technologies, Inc.'s Series F financing round.

Teon Therapeutics, Inc. has been invited to present at the Fall Private Company Showcase hosted by Solebury Trout, BMO and Davis Polk which is being held virtually on October 15, 2020.

Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) are sharing additional data showing baricitinib in combination with remdesivir reduced time to recovery and improved clinical outcomes for patients with COVID-19 infection compared with remdesivir

Bruin Biometrics LLC (BBI), has agreed for Arjo (ARJO-B.ST), a market-leading supplier of medical devices and solutions, to acquire an equity stake in Bruin Biometrics.

Reflow Medical, Inc., a California-based medical device company, announced that Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) has approved the Wingman™ CTO Catheter.